My lab is focusing on the regulation of pro-inflammatory gene expression in autoinflammatory diseases, infections and cancer. We are trying to discover new, key molecules of inflammatory signaling pathways that become deregulated under disease conditions. The overall aim is to find small molecule inhibitors that modulate these inflammatory signaling pathways, thereby identifying new therapeutic approaches. At the moment we are focusing our research on skin and skin-related diseases, such as psoriasis, S.aureus infections and melanoma.
Our approach comprises common molecular and cell biological methods (Gene expression, RNA sequencing, lentiviral knockdown or CRISPR-Cas9 knockout), protein biochemistry (Chromatin immunoprecipitation, immunoblotting, mass spectrometry), but also the generation and analysis of various mouse models.
- Since 2021: Group Leader, University Medical Centre of Johannes Gutenberg University Mainz, Department of Dermatology
- 2016 - 2021: Junior group leader, University of Tübingen, Molecular medicine
- 2013 - 2016: Postdoctoral Researcher, University of Göttingen, Molecular Oncology
- 2012 - 2013: PhD student at GGNB Göttingen, University of Göttingen
- 2009 - 2011: PhD student at Georg-Speyer Haus, Frankfurt a. Main
- 2001 - 2005: MSc, HAN University of Nijmegen/St. Radboud University Nijmegen
Selected publications by Daniela Kramer
Müller A, Dickmanns A, Resch C, Schäkel K, Hailfinger S, Dobbelstein M, Schulze-Osthoff K, Kramer D (2020) The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. The Journal of clinical investigation, 130:5765–5781. Link
Lorscheid S, Müller A, Löffler J, Resch C, Bucher P, Kurschus FC, Waisman A, Schäkel K, Hailfinger S, Schulze-Osthoff K, Kramer D (2019) Keratinocyte-derived IκBζ drives psoriasis and associated systemic inflammation. JCI insight, 4:e130835. Link
Müller A, Hennig A, Lorscheid S, Grondona P, Schulze-Osthoff K, Hailfinger S, Kramer D (2018) IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes. Proceedings of the National Academy of Sciences of the United States of America, 115:10088–10093. Link
Kramer D, Stark N, Schulz-Heddergott R, Erytch N, Edmunds S, Roßmann L, Bastians H, Concin N, Moll UM, Dobbelstein M (2017) Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells. Cell death and differentiation, 24:300–316. Link
Nemajerova A, Kramer D, Siller SS, Herr C, Shomroni O, Pena T, Gallinas Suazo C, Glaser K, Wildung M, Steffen H, Sriraman A, Oberle F, Wienken M, Hennion M, Vidal R, Royen B, Alevra M, Schild D, Bals R, Dönitz J, Riedel D, Bonn S, Takemaru K, Moll UM, Lizé M (2016) TAp73 is a central transcriptional regulator of airway multiciliogenesis. Genes & development, 30:1300–1312. Link